Barings’s Medifast MED Stock Holding History

Barings’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7,900	Closed	-$738K	–	881
2018 Q1	$738K	Hold	7,900	–	–	0.01%	593
2017 Q4	$551K	Hold	7,900	–	–	0.01%	683
2017 Q3	$469K	Hold	7,900	–	–	0.01%	660
2017 Q2	$328K	Hold	7,900	–	–	0.01%	723
2017 Q1	$351K	Hold	7,900	–	–	0.01%	780
2016 Q4	$329K	Hold	7,900	–	–	0.01%	747
2016 Q3	$299K	Hold	7,900	–	–	0.01%	683
2016 Q2	$263K	Hold	7,900	–	–	0.01%	814
2016 Q1	$239K	Hold	7,900	–	–	0.01%	851
2015 Q4	$240K	Hold	7,900	–	–	0.01%	825
2015 Q3	$212K	Hold	7,900	–	–	0.01%	845
2015 Q2	$255K	Hold	7,900	–	–	0.01%	862
2015 Q1	$237K	Hold	7,900	–	–	0.01%	876
2014 Q4	$265K	Hold	7,900	–	–	0.01%	823
2014 Q3	$259K	Hold	7,900	–	–	0.01%	841
2014 Q2	$240K	Hold	7,900	–	–	0.01%	889
2014 Q1	$230K	Hold	7,900	–	–	0.01%	856
2013 Q4	$206K	Hold	7,900	–	–	0.01%	868
2013 Q3	$212K	Hold	7,900	–	–	0.01%	866
2013 Q2	$204K	Buy	+7,900	New	+$207K	0.01%	835

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Barings's MED Position: Q2 2018 in Review

Barings sold out of Medifast (MED) in Q2 2018, closing a stake of 7,900 shares — an estimated $738K sold.

Barings first reported a position in MED in Q2 2013 and held it in 20 quarters. The position peaked at $738K in Q1 2018. 258 funds tracked by Wall St. Rank hold MED as of Q2 2018.

Barings reported no remaining Medifast position as of Q2 2018 after selling out during the quarter.
Barings sold 7,900 Medifast shares in Q2 2018, an estimated $738K.
Barings first reported a position in Medifast in Q2 2013 and held it in 20 quarters.
Barings's Medifast position peaked at $738K in Q1 2018.
258 funds tracked by Wall St. Rank held Medifast as of Q2 2018.

Based on Barings's 13F filing for Q2 2018, filed 3 Aug 2018.